SYNERGY stent

DEVICE4 trials

Sponsors

Aarhus University Hospital Skejby, University of Malaya, University Hospital Heidelberg, University Hospital, Toulouse

Conditions

Acute Coronary SyndromeCoronary Artery DiseaseIschemic Heart Disease

Unknown Phase

Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII

Aarhus University Hospital SkejbyCoronary Artery Disease, Ischemic Heart Disease

Start: 2014-02-10End: 2020-12-31Updated: 2017-04-25

ENdothelial Healing Assessment With Novel Coronary tEchnology

CompletedNCT02747199

University of MalayaCoronary Artery Disease

Start: 2015-08-31End: 2017-04-12Updated: 2017-05-04

Procedural Advantages of a Novel Drug-Eluting Coronary Stent

CompletedNCT02881216

University Hospital HeidelbergCoronary Artery Disease

Start: 2015-01-31End: 2016-06-30Updated: 2016-08-29

Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction

CompletedNCT02890589

University Hospital, ToulouseAcute Coronary Syndrome

Start: 2016-07-01End: 2018-02-01Updated: 2026-06-01

Related Papers

Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention: A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial).

2019-04-0124 citations